Cell Cybernetics A New Pathway to Peace of MindCell Cybernetics
MenuClose

Media

Select year
Sep 1 2019
Blood Health Q3 2019 – page 11 Hemogenyx Pharmaceuticals feature
The Guardian/Mediaplanet
Jul 23 2019
Removing the toxicity from bone marrow transplant conditioning
Health Awareness
May 31 2019
Hemogenyx Pharmaceuticals CEO Dr Vladislav Sandler interviewed by Zak Mir
Read
Nov 5 2018
Orgenesis teams up with Hemogenyx Pharmaceuticals to develop its AHC platform in ‘exciting’ deal
Proactive Investors
Nov 5 2018
Orgenesis teams up again with Hemogenyx Pharmaceuticals to push cancer cell replacement to clinical trials
Proactive Investors
May 21 2018
Hemogenyx Pharmaceuticals, Rockefeller University Collaborating to Develop New Lupus Therapies
Lupus News Today
May 14 2018
Hemogenyx Pharmaceuticals teams up with global pharma company to help further develop CDX antibodies
Proactive Investors
May 13 2018
Hemogenyx Pharmaceuticals shares leap as it signs collaboration deal with major US biotechnology company
Proactive Investors
May 11 2018
Hemogenyx Pharmaceuticals CEO says progress ‘definitely surpassing expectations’
Proactive Investors
Feb 27 2018
Hemogenyx Pharmaceuticals release successful CDX Antibody first data results
London South East
Load more
Cell Cybernetics A New Pathway to Peace of MindCell Cybernetics

  • Join Us
  • Contact
  • Privacy Policy

1350 Avenue of Americas, Fl 2-1017
New York, NY 10019
USA

© 2026 Cell Cybernetics. All rights reserved.